Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Urinary System Drugs >  Diuretics Drugs >  Methazolamide

Methazolamide

Basic information Safety Supplier Related

Methazolamide Basic information

Product Name:
Methazolamide
Synonyms:
  • 2-acetylimino-3-methyl-delta(sup4)-1,3,4-thiadiazoline-5-sulfonamide
  • 2-Acetylimino-3-methyl-delta4-1,3,4-thiadiazoline-5-sulfonamide
  • 5-acetylimino-4-methyl-delta(sup2)-1,3,4-thiadiazoline-2-sulfonamide
  • CL 8490
  • N-[5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide
  • N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
  • N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)ethanamide
  • Methazolamide (500 mg)
CAS:
554-57-4
MF:
C5H8N4O3S2
MW:
236.27
EINECS:
209-066-7
Product Categories:
  • VANDID
  • Other APIs
  • Heterocycles
  • Inhibitors
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Sulfur & Selenium Compounds
Mol File:
554-57-4.mol
More
Less

Methazolamide Chemical Properties

Melting point:
208 °C (dec.) (lit.)
Boiling point:
402.0±28.0 °C(Predicted)
Density 
1.6625 (rough estimate)
refractive index 
1.6270 (estimate)
storage temp. 
2-8°C
solubility 
DMSO: soluble20mg/mL, clear
form 
White powder
pka
7.30(at 25℃)
color 
white to beige
Water Solubility 
2.835g/L(25 ºC)
InChIKey
FLOSMHQXBMRNHR-QPJJXVBHSA-N
CAS DataBase Reference
554-57-4(CAS DataBase Reference)
NIST Chemistry Reference
Methazolamide(554-57-4)
EPA Substance Registry System
Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]- (554-57-4)
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
20/21/22-40
Safety Statements 
22-36
WGK Germany 
3
RTECS 
AC6350000
HS Code 
2935904000
Hazardous Substances Data
554-57-4(Hazardous Substances Data)

MSDS

More
Less

Methazolamide Usage And Synthesis

Description

Methazolamide is a carbonic anhydrase inhibitor (IC50 = 130 nM). It reduces intraocular pressure and cerebrospinal fluid flow in a rat model of glaucoma. Methazolamide reduces electroshock-induced seizures in rats with an ED50 value of 19.2 mg/kg. It also inhibits production of reactive oxygen species (ROS) in a primary cortical neuron (PCN) cellular model of subarachnoid hemorrhage (SAH) and reduces cerebral edema in a mouse model of SAH. Methazolamide is larvicidal, with a larvicidal concentration (LC50) value of 724 ppm, but has no activity when administered in the diet to adult A. aegypti. Formulations containing methazolamide have been used for the treatment of glaucoma.

Chemical Properties

White Solid

Originator

Neptazane ,Lederle,US,1959

Uses

Action of this drug is similar to that of acetazolamide, and it is used for lowering intraocular pressure in treating wide-angle and secondary glaucoma, and before surgical intervention for severe wide-angle glaucoma.

Uses

Methazolamide is a carbonic anhydrase inhibitor. Methazolamide is used in the treatment of glaucoma.

Uses

CNS & respiratory stimulant

Definition

ChEBI: Methazolamide is a member of thiadiazoles and a sulfonamide.

Manufacturing Process

A suspension of 6 parts by weight of 5-acetylimino-4-methyl-2- benzylmercapto-δ2-1,3,4-thiadiazoline in 180 parts by volume of 33% aqueous acetic acid was chlorinated at 5°C for 30 minutes. The solid was filtered off, dried, and added portion-wise to 100 parts by volume of liquid ammonia. The ammonia was removed under a stream of dry nitrogen.
The residual solid was partially dissolved in 10 parts by volume of water, filtered, and acidified to give 5-acetylimino-4-methyl-δ2-1,3,4-thiadiazoline-2- sulfonamide. The product was purified by two recrystallizations from hot water.

Therapeutic Function

Carbonic anhydrase inhibitor

Biochem/physiol Actions

Methazolamide is a cell-permeable and potent carbonic anhydrase (CA) inhibitor that is used in the treatment of glaucoma. Methazolamide is an insulin sensitizer that reduces hepatic glucose generation in animal models.

Clinical Use

Methazolamide is a derivative of acetazolamide in which one of the active hydrogens has been replaced by a methyl group. This decreases the polarity and permits a greater penetration into the ocular fluid, where it acts as a carbonic anhydrase inhibitor, reducing intraocular pressure. Its dose for glaucoma is 50 to 100 mg two to three times a day.

Synthesis

Methazolamide, N-(4-methyl-2-sulfamoyl-1,3,4-thiadiazol-5-yliden) acetamide (21.2.3), is made by an intermediate product of acetazolamide synthesis?a 2-acetylamino-5-mercapto-1,3,4-thadiazol (9.7.3). This is benzylated with benzylchloride at the mercapto group, forming 2-acetylamino-5-benzylthio-1,3,4-thiadiazole (21.2.1). Further methylation of the product with methyl iodide leads to the formation of N-(4-methyl- 2-benzylthio-1,3,4-thiadiazol-5-yliden)acetamide (21.2.2). Oxidation and simultaneous chlorination of the resulting product with chlorine in an aqueous solution of acetic acid, and reacting the resulting chlorosulfonic derivative with ammonia gives (21.2.3).

Veterinary Drugs and Treatments

Orally administered methazolamide is used for the medical treatment of glaucoma.

MethazolamideSupplier

Hangzhou Aobo Baoling Pharmaceutical Co., Ltd. Gold
Tel
4000-228211
Wellman Pharmaceutical Group Limited Gold
Tel
027-027-83778875 15807197853
Email
15807197853@163.com
Wuhan Dingxintong Pharmaceutical Co. , Ltd. Gold
Tel
027-027-83984790 17720532645
Email
t17720532645@163.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com